These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2210440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibition of hemin-induced hemolysis by desferrioxamine: binding of hemin to red cell membranes and the effects of alteration of membrane sulfhydryl groups.
    Sullivan SG, Baysal E, Stern A.
    Biochim Biophys Acta; 1992 Feb 17; 1104(1):38-44. PubMed ID: 1550852
    [Abstract] [Full Text] [Related]

  • 3. Melatonin protects human red blood cells from oxidative hemolysis: new insights into the radical-scavenging activity.
    Tesoriere L, D'Arpa D, Conti S, Giaccone V, Pintaudi AM, Livrea MA.
    J Pineal Res; 1999 Sep 17; 27(2):95-105. PubMed ID: 10496145
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhancement of hemin-induced membrane damage by artemisinin.
    Wei N, Sadrzadeh SM.
    Biochem Pharmacol; 1994 Aug 17; 48(4):737-41. PubMed ID: 8080446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of deferoxamine against Porphyromonas gingivalis.
    Moon JH, Herr Y, Kim SW, Lee JY.
    FEMS Microbiol Lett; 2011 Oct 17; 323(1):61-7. PubMed ID: 22092680
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro chelating, cytotoxicity, and blood compatibility of degradable poly(ethylene glycol)-based macromolecular iron chelators.
    Rossi NA, Mustafa I, Jackson JK, Burt HM, Horte SA, Scott MD, Kizhakkedathu JN.
    Biomaterials; 2009 Feb 17; 30(4):638-48. PubMed ID: 18977029
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of hypochlorous acid-mediated reactions by desferrioxamine. Implications for the mechanism of cellular injury by neutrophils.
    Vissers MC, Fantone JC.
    Free Radic Biol Med; 1990 Feb 17; 8(4):331-7. PubMed ID: 2165973
    [Abstract] [Full Text] [Related]

  • 15. Iron release and membrane damage in erythrocytes exposed to oxidizing agents, phenylhydrazine, divicine and isouramil.
    Ferrali M, Signorini C, Ciccoli L, Comporti M.
    Biochem J; 1992 Jul 01; 285 ( Pt 1)(Pt 1):295-301. PubMed ID: 1637315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antioxidant capacity of desferrioxamine and ferrioxamine in the chemically-initiated lipid peroxidation of rat erythrocyte ghost membranes.
    Videla LA, Cáceres T, Lissi EA.
    Biochem Int; 1988 May 01; 16(5):799-807. PubMed ID: 3421981
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro antimalarial activity of ICL670: a further proof of the correlation between inhibition of β-hematin formation and of peroxidative degradation of hemin.
    Sonnet P, Mullié C.
    Exp Parasitol; 2011 May 01; 128(1):26-31. PubMed ID: 21295029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.